PART I Item 1. Bu siness. Overview ORIC Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to improving patients lives by O vercoming R esistance I n C ancer . Profound advancements in oncology drug development have expanded the treatment options available to patients, yet therapeutic resistance and relapse continue to limit the efficacy and duration of clinical benefit of such treatments. Collectively, our founders and management team have a decades-long heritage of identif...
Q2 FY2026 — expected 2026-08-11
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-23 | 2025-12-31 | 0001193125-26-064005 | EDGAR | 99K words |
| 2025-02-18 | 2024-12-31 | 0000950170-25-022273 | EDGAR | — |
| 2024-03-11 | 2023-12-31 | 0000950170-24-029298 | EDGAR | — |
| 2023-03-16 | 2022-12-31 | 0000950170-23-008483 | EDGAR | — |
| 2022-03-21 | 2021-12-31 | 0000950170-22-004239 | EDGAR | — |
| 2021-03-23 | 2020-12-31 | 0001564590-21-014865 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001193125-25-280234 | EDGAR | 66K words |
| 2025-08-12 | 2025-06-30 | 0000950170-25-107359 | EDGAR | — |
| 2025-05-05 | 2025-03-31 | 0000950170-25-063564 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0000950170-24-125471 | EDGAR | — |
| 2024-08-12 | 2024-06-30 | 0000950170-24-095467 | EDGAR | — |
| 2024-05-06 | 2024-03-31 | 0000950170-24-053582 | EDGAR | — |
| 2023-11-06 | 2023-09-30 | 0000950170-23-059415 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0000950170-23-041362 | EDGAR | — |
| 2023-05-08 | 2023-03-31 | 0000950170-23-018839 | EDGAR | — |
| 2022-11-07 | 2022-09-30 | 0000950170-22-022631 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0000950170-22-016894 | EDGAR | — |
| 2022-05-09 | 2022-03-31 | 0000950170-22-008512 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-31 | 0001193125-26-134618 | EDGAR | 7K words |
| 2026-02-23 | 0001193125-26-064291 | EDGAR | — |
| 2026-02-23 | 0001193125-26-063974 | EDGAR | — |
| 2025-12-08 | 0001193125-25-310472 | EDGAR | — |
| 2025-11-13 | 0001193125-25-280247 | EDGAR | — |
| 2025-11-13 | 0001193125-25-280196 | EDGAR | — |
| 2025-08-12 | 0000950170-25-107313 | EDGAR | — |
| 2025-06-13 | 0001193125-25-140725 | EDGAR | — |
| 2025-05-28 | 0001193125-25-129531 | EDGAR | — |
| 2025-05-05 | 0000950170-25-063540 | EDGAR | — |
99 total filings indexed. 71 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001796280 |
| Ticker | ORIC |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.oricpharma.com |
| Listed | 2020-04-24 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report